At a glance
- Originator Merck & Co
- Class Antihypertensives
- Mechanism of Action Potassium-sparing diuretics
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypertension
Most Recent Events
- 24 Feb 1995 No-Development-Reported for Hypertension in USA (unspecified route)